Differential expression and function of alternative splicing variants of human liver X receptor α

Molecular Pharmacology

Volumn 81, Issue 6, 2012, Pages 800-810

  Endo Umeda, Kaori ^a   Uno, Shigeyuki ^a   Fujimori, Ko ^b   Naito, Yoshikazu ^c   Saito, Koichi ^c   Yamagishi, Kenji ^d,g   Jeong, Yangsik ^e   Miyachi, Hiroyuki ^f   Tokiwa, Hiroaki ^d   Yamada, Sachiko ^a   Makishima, Makoto ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c SUMITOMO CHEMICAL CO LTD   (Japan)

^d RIKKYO UNIVERSITY   (Japan)

^e Yonsei University Wonju College of Medicine   (South Korea)

^f OKAYAMA UNIVERSITY   (Japan)

^g NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HETERODIMER; HORMONE RECEPTOR BLOCKING AGENT; LIVER X RECEPTOR ALPHA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE;

ALTERNATIVE RNA SPLICING; ARTICLE; CODON; CONTROLLED STUDY; DIMERIZATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CODON, TERMINATOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORPHAN NUCLEAR RECEPTORS; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84861417926     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.077206     Document Type: Article

References (35)

1. Adachi R, Shulman AI, Yamamoto K, Shimomura I, Yamada S, Mangelsdorf DJ, and Makishima M (2004) Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol Endocrinol 18:43-52. (Pubitemid 38073152)
2. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA, Jamieson BD, et al. (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97-111. (Pubitemid 351905740)
3. Blaschke F, Leppanen O, Takata Y, Caglayan E, Liu J, Fishbein MC, Kappert K, Nakayama KI, Collins AR, Fleck E, et al. (2004) Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ Res 95:e110-123.
4. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, and Rastinejad F (2008) Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA. Nature 456:350-356.
5. Chang YF, Imam JS, and Wilkinson MF (2007) The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76:51-74.
6. Chen M, Beaven S, and Tontonoz P (2005) Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha. J Lipid Res 46:2570-2579. (Pubitemid 43107468)
7. Cooper TA, Wan L, and Dreyfuss G (2009) RNA and disease. Cell 136:777-793.
8. Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, and Liao S (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 64:7686-7689. (Pubitemid 39446897)
9. Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, and Xu HE (2000) Asymmetry in the PPARγ/ RXRαcrystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 5:545-555.
10. 3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Mol Pharmacol 71:1298-1311.
11. Ishizawa M, Matsunawa M, Adachi R, Uno S, Ikeda K, Masuno H, Shimizu M, Iwasaki K, Yamada S, and Makishima M (2008) Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res 49:763-772.
12. Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O'Connell RM, Cheng G, Saez E, et al. (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309. (Pubitemid 39360910)
13. Kaneko E, Matsuda M, Yamada Y, Tachibana Y, Shimomura I, and Makishima M (2003) Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem 278:36091-36098. (Pubitemid 37139930)
14. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, and Tontonoz P (2001) Autoregulation of the human liver X receptor α promoter. Mol Cell Biol 21:7558-7568. (Pubitemid 32988767)
15. Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C, and Lala DS (2002) Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism. Mol Endocrinol 16:506-514. (Pubitemid 34214570)
16. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, and Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515.
17. Makishima M (2005) Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci 97:177-183.
18. Noguchi-Yachide T, Aoyama A, Makishima M, Miyachi H, and Hashimoto Y (2007) Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors. Bioorg Med Chem Lett 17:3957-3961. (Pubitemid 46920933)
19. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, and Brown MS (2001) Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 98:6027-6032. (Pubitemid 32488187)
20. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, and Mangelsdorf DJ (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93:693-704. (Pubitemid 28257577)
21. Repa JJ and Mangelsdorf DJ (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 8:1243-1248. (Pubitemid 35373555)
22. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, and Mangelsdorf DJ (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289:1524-1529.
23. Rosenfeld MG, Lunyak VV, and Glass CK (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428. (Pubitemid 43830648)
24. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al. (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831-2838.
25. Shin C and Manley JL (2004) Cell signalling and the control of pre-mRNA splicing. Nat Rev Mol Cell Biol 5:727-738. (Pubitemid 39208182)
26. Spencer TA, Li D, Russel JS, Collins JL, Bledsoe RK, Consler TG, Moore LB, Galardi CM, McKee DD, Moore JT, et al. (2001) Pharmacophore analysis of the nuclear oxysterol receptor LXRα. J Med Chem 44:886-897. (Pubitemid 32861613)
27. Svensson S, Ostberg T, Jacobsson M, Norström C, Stefansson K, Hallén D, Johansson IC, Zachrisson K, Ogg D, and Jendeberg L (2003) Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand-binding domains in a fully agonistic conformation. EMBO J 22:4625-4633. (Pubitemid 37162899)
28. Tontonoz P and Mangelsdorf DJ (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17:985-993. (Pubitemid 36683707)
29. Uno S, Endo K, Jeong Y, Kawana K, Miyachi H, Hashimoto Y, and Makishima M (2009) Suppression of β-catenin signaling by liver X receptor ligands. Biochem Pharmacol 77:186-195.
30. Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M, and Glass CK (2004) Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 101:17813-17818. (Pubitemid 40051969)
31. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, and Steffensen KR (2009) The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30:575-579.
32. Wahl MC, Will CL, and Lührmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701-718.
33. Williams S, Bledsoe RK, Collins JL, Boggs S, Lambert MH, Miller AB, Moore J, McKee DD, Moore L, Nichols J, et al. (2003) X-ray crystal structure of the liver X receptor β ligand binding domain: regulation by a histidine-tryptophan switch. J Biol Chem 278:27138-27143. (Pubitemid 36876869)
34. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, and Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033-1045.
35. Yoshikawa T, Shimano H, Amemiya-Kudo M, Yahagi N, Hasty AH, Matsuzaka T, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, et al. (2001) Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol 21:2991-3000. (Pubitemid 32298367)